Increasing Incidence of Cancer Leads to High Adoption of Biopsy Devices in US
Biopsy is a medical procedure involving extraction of sample
cells/tissues from a tumor for examination and diagnosis of malignancy. The
procedure is performed in two ways- needle-based minimally invasive procedures
and open surgical procedures. Increasing incidence of cancer is has led to high
adoption of these devices. For instance, according to the American Cancer
Society, in 2019, there will be an estimated 1,762,450 new cancer cases
diagnosed and 606,880 cancer deaths in the U.S.
Such scenario has thus led to approval and launch of new biopsy
devices in the country. For instance, in December 2019, Medtronic plc received
the U.S. Food and Drug Administration clearance for its Stealth Autoguide
system, for biopsy procedures, stereoelectroencephalography (sEEG) depth
electrode placement, and for the positioning of the Visualase bone anchor,
which is used for catheter placement.
Currently, there are approximately 35 different types of devices
available in the global biopsy
devices market. This device field is expanding at a rapid pace due to the
development of new techniques and the application of advanced technology. It
will continue to impact the lives of thousands of individuals who take
advantage of the convenience and value of these instruments every day. In the
future, these innovations may benefit even those patients who undergo frequent
or repeated biopsies.
A mammotome breast biopsy device, a vacuum-assisted breast biopsy
(VAC) device that uses image guidance such as x-ray, ultrasound and/or MRI to
perform breast biopsies, has been in use in more than 5 million exams
worldwide. It's easy to use, extremely accurate and produces little or no
discomfort. Yet, the Mammotome breast biopsy instruments are also highly
effective in helping doctors diagnose a wide variety of breast cancers, from
the ones you can feel to those you can't feel (non-pampering lesions).
The most common type of mammographic instrument is the wand-like probe
called an end cutter. These devices can perform both manual and robotic end
cutting procedures. End cutting means the doctor inserts the probe into a
crease on your breast and removes it later. Robotic end cutting means the
doctor simultaneously inserts the probe into the crease, applies pressure and
removes it. Because the probe is so small, many end cut tools require a minimal
amount of lubrication between the equipment and your skin. This lubricant
prevents the end cutting action from damaging your skin.
Another popular type of mammography instrument is the syringe-like
cannula. These annual devices have a tube with a tiny amount of liquid inside
where a long needle tip fits. As the cannula is lowered into your breast
tissue, the needle tip injects a small amount of liquid typically containing
anesthetic and/or medication into your tissue. Many of today's most advanced
syringe-like cannula instruments are able to simultaneously remove tumors and
lift and fix benign lesions.
Biopsy, Biopsy devices, Biopsy system, Breast Biopsy devices, Needle
based Biopsy Guns, Biopsy Needles, Biopsy Forceps, Biopsy Guidance Systems
Comments
Post a Comment